Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiology and Hospital Management of Patients With PROS in France: a PMSI Study

NCT07222423 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT07222423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiology and Hospital Management of Patients With PROS in France: a PMSI Study
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
January 15, 2024
Completion date
October 8, 2024
Enrollment
3,605 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pik3ca-related overgrowth spectrum